aldosterone has been researched along with Cardiotoxicity in 1 studies
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enalapril treatment in the chronic model, however, protected against cardiac dysfunction and cardiomyocyte atrophy and was associated with increased activation of the PI3K/AKT/mTOR pathway along with normal levels of CTGF." | 5.48 | Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity. ( Basquin, D; Hullin, R; Maillard, M; Martin, D; Métrich, M; Regamey, J; Sarre, A, 2018) |
| "Enalapril treatment in the chronic model, however, protected against cardiac dysfunction and cardiomyocyte atrophy and was associated with increased activation of the PI3K/AKT/mTOR pathway along with normal levels of CTGF." | 1.48 | Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity. ( Basquin, D; Hullin, R; Maillard, M; Martin, D; Métrich, M; Regamey, J; Sarre, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hullin, R | 1 |
| Métrich, M | 1 |
| Sarre, A | 1 |
| Basquin, D | 1 |
| Maillard, M | 1 |
| Regamey, J | 1 |
| Martin, D | 1 |
1 other study available for aldosterone and Cardiotoxicity
| Article | Year |
|---|---|
Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotoxicity; Connective Tissue Gr | 2018 |